If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
61.50    -2.00 (-3.15%)
Bid:
60.00
Ask:
63.00
Spread: 3.00 (5.00%)
Market Cap: £54.17m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Acquisition & Trading Update

11 Jul 2005 07:00

Calyx Group PLC11 July 2005 FOR IMMEDIATE RELEASE 11 July 2005 Calyx Group plc ("Calyx") Acquisition of Convergent and Trading Update Calyx, one of the largest single-source providers of information andcommunication technology ("ICT") network solutions throughout Ireland, todayannounces the acquisition of Convergent Systems Ireland Ltd ("Convergent"), aleading Irish supplier of communication solutions, for a total consideration ofup to €0.6 million (£0.41 million) in cash. Calyx has a broad client base to which it offers ICT network design, sales,installation, training and support and recently completed a successful Placingand Admission to AIM. Convergent was set up in December 1999 and delivers professional services,including consultancy, project management, installation, & support of voice anddata products to a wide range of business sectors. As an Avaya BusinessPartner, Convergent specialises in helping their customers to maximize the useof their existing voice and data infrastructures to reduce costs and improveefficiency. The Convergent client base includes Citigroup, One Direct, AmericanHolidays, AVX, Micros Fidellio, Dublin Tourism, Sportingbet Ireland, Accentureand Norfolkline. The Convergent acquisition will enhance Calyx's skill set particularly inrelation to professional services and systems integration. They also bring ahealthy client portfolio and a positive, ambitious approach to the convergingvoice and data market. For the year-end 31 August 2004, the most recent year of which audited figureshave been published; Convergent had revenues of €1.3 million, EBITDA of €0.25million and gross book value assets of €0.66 million. The acquisition of Convergent will be settled by an initial consideration of€0.3 million with a further earn-out payment of up to €0.3 million payable inJuly 2006, subject to appropriate performance criteria being met. Calyx Trading Update First half trading has been strong and is in line with managements'expectations, which were highlighted at the time of the Placing and Admission toAIM. Calyx continues to experience favourable trading conditions and the Boardremains confident about the prospects for the full year. Calyx will update the market on further progress at its interim results, for the6 months ended 30 June 2005, which will be announced in August 2005. Maurice Healy, Chief Executive of Calyx, commenting on the acquisition said; "I am pleased to announce the acquisition of Convergent, following our strongfirst 3 months as a public company. This acquisition is part of our continuingacquisition strategy, as set out at the time of our Placing, and will be anideal synergistic fit. We will continue to seek appropriate acquisitions whichthe Board believe will further enhance Calyx's position within the market andprovide us with the ability to expand our services throughout Europe." For further details please contact: Calyx Group plc Maurice Healy, Chief Executive Tel: +353 1 676 3363 Buchanan Communications Tim Thompson / James Strong Tel: +44 (0)20 7466 5000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th May 20239:00 amRNSPDMR Dealings
4th May 20237:00 amRNSNotice of Results and Investor Presentation
14th Apr 20236:03 pmRNSPDMR Dealings
14th Apr 20233:24 pmRNSDirector Dealing
15th Mar 20231:15 pmRNSDirector Dealings
14th Mar 20234:00 pmRNSPDMR Dealings
7th Mar 20239:05 amRNSSecond Price Monitoring Extn
7th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSTrading Update
15th Feb 202310:59 amRNSPDMR Dealings
19th Jan 20239:56 amRNSPDMR Dealings
17th Jan 20239:56 amRNSDirector / PDMR Dealings
17th Jan 20239:52 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSBoard Changes
13th Jan 20234:00 pmRNSDirector/PDMR Dealing
13th Dec 20222:15 pmRNSDirector / PDMR Dealings
22nd Nov 20227:00 amRNSInterim Results
21st Nov 20225:43 pmRNSDirector / PDMR Dealings
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
14th Oct 20223:53 pmRNSDirector/PDMR Shareholding
12th Oct 20221:29 pmRNSDirector / PDMR Dealings
15th Sep 20227:30 amRNSDirector/PDMR Dealing
17th Aug 20225:26 pmRNSResult of AGM
17th Aug 20227:00 amRNSAGM Statement
15th Aug 202210:26 amRNSDirector / PDMR Dealings
26th Jul 20223:33 pmRNSDirector / PDMR Shareholding
18th Jul 20227:00 amRNSNotice of AGM
14th Jul 20225:49 pmRNSDirector/PDMR Dealings
8th Jul 20226:01 pmRNSDirector / PDMR dealings
15th Jun 20227:00 amRNSExercise of Options
14th Jun 20227:00 amRNSBoard Update
6th Jun 20221:30 pmRNSDirector Dealing
24th May 20227:00 amRNSFY22 Final Results
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.